Test Your Hypothesis

 BGPT Odds of True

The hypothesis asserts genotype-dependent shielding effects on infant EEG coherence. Genotype-dependent neural synchrony changes in Cntnap2 models are supported (mouse theta hyper-synchrony, EEG abnormalities), but no supplied or known evidence supports any effect of Faraday shielding on infant neural development, making the full interaction claim unlikely as stated.

 Hypothesis Novelty

Combining CNTNAP2 genotype with a Faraday-shielding environment in a longitudinal newborn EEG design is an unusual gene-environment interaction framing not present in mainstream autism-connectivity literature; only the genotype-synchrony component is familiar.

 Quick Analysis Plan Copied

 Long Analysis Plan

Splitting the hypothesis into testable components

The hypothesis contains two claims requiring separate evaluation: (1) CNTNAP2 risk status modulates EEG coherence trajectories over 24 months, and (2) Faraday shielding during rest/sleep produces a stronger genotype-dependent divergence between shielded and unshielded arms. Component (1) has indirect mechanistic support; component (2) has zero supplied evidentiary support and rests on an unvalidated assumption that ambient electromagnetic exposure measurably shapes infant cortical synchrony.

What the evidence does support: genotype-dependent neural synchrony

Cntnap2-deficient mice show elevated baseline theta power and hyper-synchronous theta coherence across prefrontal-limbic circuits (PrL–PVN), measured directly with LFP coherence analysis (Hyper-synchronous theta coherence in Cntnap2 KO). Independently, Cntnap2 loss yields EEG-detectable seizure susceptibility via reticular thalamic hyperexcitability (Reticular thalamic hyperexcitability with EEG changes), and the original knockout characterization reported epileptiform activity, neuronal migration abnormalities, and reduced interneurons (Foundational Cntnap2 knockout EEG phenotype). These findings make it biologically plausible that CNTNAP2 status biases coherence trajectories — but all evidence is murine, adult or juvenile, and uses invasive LFP/electrode recordings, not scalp EEG in human newborns. Human CNTNAP2 variant-carrier EEG coherence data are absent from the supplied records.

What the evidence does not support: the Faraday-shielding interaction

No supplied record measures or models effects of ambient electromagnetic fields or their shielding on neural development, EEG coherence, or any genotype-by-environment interaction. The shielded/unshielded arm design assumes (a) ambient EM exposure alters infant EEG trajectories measurably over 24 months, (b) this effect is large enough to detect against the enormous developmental and environmental variance in newborn cohorts, and (c) CNTNAP2 carriers are differentially sensitive. None of these assumptions has cited support; each is a hidden leap. Without a dose-response or mechanistic pathway linking ambient fields to cortical synchrony, the two-arm design risks being uninterpretable if a null result occurs (no exposure contrast) or confounded if it does not (shielding may co-vary with parenting conditions, room acoustics, temperature). The trajectory-by-genotype interaction logic itself is sound and parallels observed genotype-dependent learning divergences in Cntnap2 models, e.g., Barnes maze hazard ratios of 1.21/day in WT versus ~0.01–0.17 in knockouts (Genotype-dependent trajectory divergence in Cntnap2 KO).

Figure: sourced Barnes maze hazard ratios (Barnes maze hazard ratio data), replotted as cumulative divergence to illustrate the genotype-by-time interaction structure the hypothesis invokes in humans.

Key limitations, blind spots, and falsification criteria

• Species and age gap: all coherence evidence is from adult/adolescent mice with depth electrodes; newborn scalp EEG coherence in human carriers is unmeasured in supplied data.
• Gene definition: "risk-variant" is undefined — CNTNAP2 has multiple reported variants with inconsistent effect replication; the hypothesis must pre-specify variant(s) and effect sizes.
• Exposure mechanism undefined: no supplied evidence identifies what ambient field component (frequency, intensity) would plausibly affect cortical synchrony, or whether shielding differs biologically from unshielded sleep conditions.
• Multiple comparisons: EEG coherence across many electrode pairs, bands, and timepoints over 24 months creates severe multiple-testing burden; genotype-stratified interaction tests quadruple the required sample.
• Falsification: the hypothesis is falsified if carrier and non-carrier shielded-vs-unshielded trajectory differences do not differ (non-significant genotype × shielding × time interaction), or if shielding shows no main effect on coherence trajectories.

Verdict: biologically plausible genotype-synchrony foundation; unsupported and currently untestable-as-stated shielding interaction. Confidence in this assessment is moderate; the decisive missing evidence is any human newborn dataset linking ambient EM exposure or shielding to EEG coherence trajectories, and replication of CNTNAP2 variant effects on early-life human coherence.